2016
DOI: 10.4183/aeb.2016.344
|View full text |Cite
|
Sign up to set email alerts
|

Orbital Pseudotumor Can Mimic Graves’ Ophthalmopathy

Abstract: context. Orbital pseudotumor (OP) is a benign inflammatory process of the orbit with a large polymorphous lymphoid infiltrate, associated with fibrosis in variable amounts, localized or diffuse. Graves' ophthalmopathy (GO) is the most common cause of proptosis, unilateral or bilateral. case report. We report a patient with unilateral proptosis who was initially treated with antithyroid drugs for an euthyroid Graves disease, but the extension of the investigation infirmed this. The MRI findings (inflammation of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Similar cases have been described in specialized literature, including a case in our clinic published in 2016, referring to a patient with unilateral ocular modifications and thyroid dysfunction, initially diagnosed with GO, but later established as orbital pseudotumour, due to repeated negative TRAb values, MRI results, and orbital biopsy which confirmed the OP aspect. (16) Systemic glucocorticoids are the main therapy in orbital pseudotumor, as well as the first choice of treatment in moderate and severe Graves ophthalmopathy, due to their antiinflammatory and immunosuppressive effects, with a prompt response and better tolerability when administered intravenously. (9,17) Numerous studies on the efficiency of oral and intravenous corticotherapy have been performed over time and have proved the importance of this therapeutic method.…”
Section: Discussionmentioning
confidence: 99%
“…Similar cases have been described in specialized literature, including a case in our clinic published in 2016, referring to a patient with unilateral ocular modifications and thyroid dysfunction, initially diagnosed with GO, but later established as orbital pseudotumour, due to repeated negative TRAb values, MRI results, and orbital biopsy which confirmed the OP aspect. (16) Systemic glucocorticoids are the main therapy in orbital pseudotumor, as well as the first choice of treatment in moderate and severe Graves ophthalmopathy, due to their antiinflammatory and immunosuppressive effects, with a prompt response and better tolerability when administered intravenously. (9,17) Numerous studies on the efficiency of oral and intravenous corticotherapy have been performed over time and have proved the importance of this therapeutic method.…”
Section: Discussionmentioning
confidence: 99%
“…Blood tests measuring IgG4, interleukin 2 receptor, thyroid autoantibodies (thyroid-stimulating hormone, receptor antibodies, anti-thyroid peroxidase antibodies, and anti-thyroglobulin antibodies), blood counts, C-reactive protein, angiotensin-converting enzyme, Serine proteinase 3-anti-neutrophil cytoplasmic antibody, and myeloperoxidase-anti-neutrophil cytoplasmic antibody were performed. We investigated the possibility of diseases such as lymphoma, thyroid eye disease, 16 orbital cellulitis, 17 ANCA-related vasculitis, 18 , 19 and sarcoidosis. 20 , 21 We confirmed the presence of dilatation of the superior ophthalmic vein, the presence of an orbital mass on MRI, and the presence of diseases such as orbital tumors and carotid-cavernous fistulae.…”
Section: Methodsmentioning
confidence: 99%